Metformin Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Sandoz, is a biguanide presented as a tablet (strength not specified) for oral use. It lowers blood glucose levels, improves insulin sensitivity, and is indicated for long‑term glycaemic control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and serving hospitals, pharmacies, and clinics worldwide. The company provides reliable sourcing, regulatory documentation, and logistics support for global healthcare providers.

Metformin Sandoz is an oral antidiabetic agent used within the glucose‑lowering therapeutic pathway.

- Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes. - Polycystic ovary syndrome (PCOS): may improve insulin resistance and menstrual regularity (off‑label).

Metformin Sandoz may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset, often transient. - Diarrhea: loose stools, usually early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient metallic sensation in mouth.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: uncommon when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: may develop with long‑term use, leading to anemia or neuropathy.

Metformin Sandoz should be used with careful clinical monitoring.

- Renal function: assess creatinine clearance before initiating and periodically monitor. - Hepatic impairment: avoid in patients with significant liver disease. - Cardiovascular status: use cautiously in heart failure due to lactic acidosis risk. - Concomitant medications: review for drugs that may increase lactic acidosis risk (e.g., iodinated contrast). - Pregnancy and lactation: evaluate risk‑benefit; generally avoided unless clearly needed. - Store at ambient temperature: keep below 25 °C, in original container, protect from moisture.

Metformin Sandoz can interact with several medicines; clinical assessment is required.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Alcohol: can increase risk of lactic acidosis. - Cimetidine: may raise metformin plasma levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium. - Diuretics: assess for dehydration and renal impairment. - Sulfonylureas: increased risk of hypoglycemia, adjust dose if needed.